BL Pharmtech Corp
065170
Company Profile
Business description
BL Pharmtech Corp is engaged in manufacturing and sales of health foods (health functional foods, health-oriented foods, etc.) and in vitro diagnostic medical devices. The health foods division is subdivided into OEM/ODM manufacturing and distribution through home shopping and online channels. The in vitro diagnostic medical device manufacturing and sales division engages in research and development, manufacturing, and sales of in vitro diagnostic medical devices.
Contact
134, 767 Shinsuro, Suji-gu
Dongcheon-dong, Bundang Suji U-Tower Knowledge Industry Center
Gyeonggi-do
Yongin-si
KORT: +82 234014490
Sector
Consumer Defensive
Stock type
Defensive
Industry
Food Distribution
Fiscal Year End
31 December 2026
Employees
12
Stocks News & Analysis
stocks
Ask the analyst: Where does GYG stand following its US exit?
All roads lead back home for Guzman Y Gomez.
stocks
Chart of the Week: The long term headwinds facing copper shares
The key factors challenging the bull case for copper demand.
stocks
Australia’s oldest REIT undervalued
This REIT remains undervalued as trophy properties shine through.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,048.30 | 74.60 | 0.83% |
| CAC 40 | 8,508.07 | 33.21 | 0.39% |
| DAX 40 | 25,779.31 | 198.43 | 0.78% |
| Dow JONES (US) | 52,900.07 | 594.83 | 1.14% |
| FTSE 100 | 10,679.03 | 26.16 | 0.25% |
| HKSE | 23,350.03 | 295.00 | 1.28% |
| NASDAQ | 25,832.67 | 207.36 | -0.80% |
| Nikkei 225 | 69,744.07 | 1,010.92 | 1.47% |
| NZX 50 Index | 13,618.42 | 36.23 | 0.27% |
| S&P 500 | 7,483.24 | 0.01 | 0.00% |
| S&P/ASX 200 | 8,844.40 | 75.10 | 0.86% |
| SSE Composite Index | 4,043.64 | 14.74 | 0.37% |